EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
News
/
News and information
/
Kexing Biopharm...
Kexing Biopharm's Product List (FDA and EMA Approved)
Article source：Kexing Biopharm
Jun 17,2025
View： 1871
LABEL:
< Harnessing the Power of Recombinant Collagen Repair Mask for Youthful Skin
Kexing Biopharm's Product Introduction >
BACK TO LIST
Related News
Oct 13,2023
Celebrating Medical Advancements: The Marvel of Paclitaxel Injection
READ MORE >>
Oct 06,2023
Kexing Biopharm Holds China-MENA & South Asia Pharmaceutical Cooperation High-end Forum, Aiming at Foreign Emerging Markets
READ MORE >>
Apr 09,2024
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
READ MORE >>
Jan 02,2025
Artificial Intelligence in Protein Design: Applications and Prospects
READ MORE >>
Jun 17,2024
Kexing Biopharm Accelerates Global Commercialization with Successful INVIMA GMP Inspection
READ MORE >>
Oct 29,2024
Kexing Biopharm: A leader in China Recombinant Protein Therapeutics Industry
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
Article source：Kexing Biopharm
Jun 17,2025
View：
1871 
BACK TO LIST
Oct 13,2023
